medigraphic.com
ISSN 0210-5187 (Electronic)

2014, Number 4-6

<< Back Next >>

Med Cutan Iber Lat Am 2014; 42 (4-6)

Kaposi varicelliform eruption in a series of 8 patients

Ortiz K, Iranzo P, Mascaró JM, Mercè AM, Estrach T

Language: Spanish
References: 30
Page: 97-103
PDF size: 403.86 Kb.


ABSTRACT

Introduction: Kaposi varicelliform eruption (KVE) is a potentially life-threatening disseminated cutaneous viral infection occurring in patients with a prior cutaneous condition. Atopic dermatitis is usually the most common predisposing condition, although it can occur in other dermatoses. The clinical characteristics, diagnostic tests, treatment and course of eight patients with KVE admitted to a tertiary hospital over a period of 15 years are reviewed. Methods: A retrospective analysis of 8 patients hospitalized between 1995 and 2010 with a diagnosis of KVE. Results: Five women and 3 men were included, with a mean age of 47.3 years. Associated dermatoses were: atopic dermatitis (2 patients), benign familial pemphigus (2 patients), and 1 patient with each of the following diseases: pemphigus vulgaris, pemphigus foliaceus, Sezary syndrome and Darier’s disease. HSV-1 was isolated in 3 patients (one of them also had a co-infection with HSV-2). Six patients were treated with intravenous acyclovir 5-10 mg/kg/8 h, and 2 patients with oral valacyclovir. All patients had a complete resolution of the lesions, but recurrence was observed in 2 patients, at 6 and 12 months. Comment: Clinical suspicion and diagnostic confirmation of KVE is important when disseminated vesicles appear in patients with prior dermatoses in order to establish early treatment to and avoid possible complications.


REFERENCES

  1. Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol. 2003; 49: 198-205.

  2. Sterling JC. Virus infections. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. 8th ed. Oxford: Blackwell Publishing Ltd; 2010; 33: 35-6.

  3. Yang JS, Kim KM, Lee GJ, Kim IH, Oh CH. Eczema herpeticum in Darier’s disease. Ann Dermatol. 1998; 10: 32-4.

  4. Flint ID, Spencer DM, Wilkin JK. Eczema herpeticum in association with familial benign chronic pemphigus. J Am Acad Dermatol. 1993; 28: 257-9.

  5. Monsálvez V, Polo I, Fuertes L, Zarco C, Vanaclocha F. Eczema herpético en linfomas cutáneos de células T. Actas Dermosifiliogr. 2009; 100 (5): 431-3.

  6. Demitsu T, Kakurai M, Azuma R, Hiratsuca Y, Yamada T, Yoneda K. Recalcitrant pemphigus foliaceus with Kaposi’s varicelliform eruption: report of a fatal case. Clin Exp Dermatol. 2008; 33: 681-2.

  7. Koosan MK, Fogelman JP, Stern RL. Kaposi’s varicelliform eruption in a patient with Grover’s disease. J Am Acad Dermatol. 2003; 49: 914-5.

  8. Paradisi A, Capizzi R, Guerriero G, Rotoli M, Bussoletti C, Amerio PL. Kaposi’s varicelliform eruption complicating allergic contact dermatitis. J Am Acad Dermatol. 2006; 54: 732-3.

  9. Santmyire-Rosenberg BR, Nigra TP. Psoriasis herpeticum: three cases of Kaposi’s varicelliform eruption in psoriasis. J Am Acad Dermatol. 2005; 53: 52-6.

  10. Erdag G, Lockman D, Tromberg J, Cropley T, Patterson JW. A case of pityriasis rubra pilaris with associated focal acantholytic dyskeratosis complicated by Kaposi’s varicelliform eruption. J Cutan Pathol. 2011; 38: 919-22.

  11. Mallo-García S, Coto-Segura P, Suárez-Casado H, Caminal L, Sánchez-del-Río J, Santos-Juanes J. Fatal outcome due bacterial superinfection of eczema herpeticum in a patient with mycosis fungoides. Dermatol Online J. 2008; 15: 14-21.

  12. Brion N, Guillaume JC, Dubertret L, Touraine R. Disseminated cutaneous herpes of the adult and Sézary syndrome. Ann Dermatol Venereol. 1981; 108: 517-21.

  13. Ajith C, Dogra S, Handa S. Kaposi’s varicelliform eruption in a patient with phenytoin-induced drug rash. Int J Dermatol. 2006; 45: 1452-3.

  14. Kucukyilmaz I, Alpsoy E, Yazar S. Kaposi’s varicelliform eruption in association with rosaceous. J Am Acad Dermatol. 2004; 51 (Suppl. 5): S169S-72.

  15. Barrio J, Lázaro P, Barrio JL. Kaposi’s varicelliform eruption and staphylococcal scalded skin syndrome in adults. J Am Acad Derrmatol. 1997; 37: 510-1.

  16. Bartralot R, García-Patos V, Rodriguez-Cano L. Kaposi’s varicelliform eruption in a patient with healing second degree burns. Clin Exp Dermatol. 1996; 21: 127-30.

  17. Bestue M, Cordero A. Kaposi’s varicelliform eruption in a patient with healing peribucal dermabrasion. Dermatol Surg. 2000; 26: 939-40.

  18. Rodríguez-Serna M, Mercader P, Pardo J, Fortea-Baixauli JM, Aliaga A. Kaposi’s varicelliform eruption in an HIV-positive patient after laser resurfacing. J Eur Acad Dermatol Venereol. 2004; 18: 711-2.

  19. Niimura M, Nishikawa T. Treatment of eczema herpeticum with oral acyclovir. Am J Med. 1988; 85: 49-52.

  20. Frish S, Siegfried MD. The clinical spectrum and therapeutic challenge of eczema herpeticum. Pediatric Dermatology. 2011; 28: 46-52.

  21. Zirn JR, Tompkins SD, Huie C, Shea CR. Rapid detection and distinction of cutaneous herpes virus infections by direct immunofluorescence. J Am Acad Dermatol. 1995; 33: 724-8.

  22. Peng WM, Jenneck C, Busmann C, Bogdanow M, Hart J, Leung DY et al. Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol. 2007; 127: 1261-3.

  23. Goodyear HM, McLeish P, Randall S, Buchan A, Skinner GR, Winther M et al. Immunological studies of herpes simplex virus infection in children with atopic eczema. Br J Dermatol. 1996; 134: 85-93.

  24. Hata TR, Kotol P, Boguniewicz M, Taylor P, Paik A, Jackson M et al. History of eczema herpeticum is associated with the inability to induce human B-defensin (HBD)-2, HBD-3 and cathelicidin in the skin in patients with atopic dermatitis. Br J Dermatol. 2010; 163: 659-61.

  25. Lubbe J, Pournaras CC, Saurat JH. Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology. 2000; 201: 249-51.

  26. Segura S, Romero D, Carrera C, Iranzo P, Estrach T. Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream. Acta Derm Veneorol. 2005; 85: 524-5.

  27. Osawa K, Etoh T, Ariyoshi N, Ishii I, Ohtani M, Kariya S et al. Relationship between Kaposi’s varicelliform eruption in Japanese patients with atopic dermatitis treated with tacrolimus ointment and genetic polymorphisms in the IL-18 gene promoter region. J Dermatol. 2007; 34: 531-6.

  28. Kim M, Jung M, Hong SP, Jeon H, Kim MJ, Cho MY et al. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp Dermatol. 2010; 19: 501-10.

  29. Wollenberg A, Wetzel S, Burgdorf WH, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol. 2003; 112: 667-74.

  30. Wheeler CE Jr, Abele DC. Eczema herpeticum, primary and recurrent. Arch Dermatol. 1966; 93: 162-7.




2020     |     www.medigraphic.com